World's Best Scientists 2026 revealed!
Ele Ferrannini

Ele Ferrannini

Award Badge
Best Scientists
2025

D-Index & Metrics

Best Scientists

D-Index
170
Citations
146358
World Ranking
858
National Ranking
13

Medicine

D-Index
171
Citations
148208
World Ranking
499
National Ranking
13

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award

Overview

Ele Ferrannini is affiliated with the University of Pisa in Italy and has a research focus primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their scientific work spans several subfields including Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Physiology, and Epidemiology.

The researcher's main topics of investigation include Diabetes Treatment and Management, Pancreatic function and diabetes, Metabolism in relation to Diabetes and Cancer, Diabetes Management and Research, Diet and metabolism studies, Liver Disease Diagnosis and Treatment, and Metabolomics and Mass Spectrometry Studies.

Frequent co-authors collaborating with Ele Ferrannini include Andrea Mari, Eleni Rebelos, Pirjo Nuutila, Andrea Natali, and Giulia Ferrannini.

The scientist has contributed extensively to various academic journals, with recurrent publications appearing in:

  • Diabetes Care
  • Diabetes
  • Diabetes Obesity and Metabolism
  • The Journal of Clinical Endocrinology & Metabolism
  • Cardiovascular Diabetology

Notable recent papers authored or co-authored by Ele Ferrannini include:

  • Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial (2021), published in The Lancet Diabetes & Endocrinology
  • Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study (2020), published in Diabetes Care
  • Anti-inflammatory properties of antidiabetic drugs: A "promised land" in the COVID-19 era? (2020), published in Journal of Diabetes and its Complications
  • Genome-Wide Association Study of Peripheral Artery Disease (2021), published in Circulation Genomic and Precision Medicine
  • Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET Cohort (2021), published in Diabetes Care

Best Publications

  • Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease

    Ralph A. DeFronzo;Eleuterio Ferrannini

  • Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    David M. Nathan;John B. Buse;Mayer B. Davidson;Ele Ferrannini

  • Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Silvio E. Inzucchi;Richard M. Bergenstal;John B. Buse;Michaela Diamant

  • Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Silvio E Inzucchi;Richard M Bergenstal;John B Buse;Michaela Diamant

  • The Metabolic Syndrome: Time for a Critical Appraisal Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

    Richard Kahn;John Buse;Ele Ferrannini;Michael Stern

  • Insulin resistance in essential hypertension

    Eleuterio Ferrannini;Giuseppe Buzzigoli;Riccardo Bonadonna;Maria Antonietta Giorico

  • Pathogenesis of NIDDM: A balanced overview

    Ralph A DeFronzo;Riccardd C Bonadonna;Eleuterio Ferrannini

  • Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    Silvio E. Inzucchi;Richard M. Bergenstal;John B. Buse;Michaela Diamant

  • Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

    Lars Rydén;Eberhard Standl;Małgorzata Bartnik;Greet Van den Berghe

  • Defining the role of common variation in the genomic and biological architecture of adult human height

    Andrew R. Wood;Tonu Esko;Jian Yang;Sailaja Vedantam

  • The theoretical bases of indirect calorimetry: a review

    Eleuterio Ferrannini

  • Type 2 diabetes mellitus.

    Ralph A. DeFronzo;Ele Ferrannini;Leif Groop;Robert R. Henry

  • Genetic studies of body mass index yield new insights for obesity biology

    Adam E. Locke;Bratati Kahali;Sonja I. Berndt;Anne E. Justice

  • Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome

    E. Ferrannini;E. Ferrannini;S. M. Haffner;B. D. Mitchell;M. P. Stern

  • Effect of fatty acids on glucose production and utilization in man.

    Eleuterio Ferrannini;Eugene J. Barrett;Stefano Bevilacqua;Ralph A. Defronzo

  • Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379

    SE Inzucchi;RM Bergenstal;JB Buse;M Diamant

  • Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

    Ele Ferrannini;Andrea Natali;Patrick Bell;Paolo Cavallo-Perin

  • Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized?

    Robert H. Eckel;Steven E. Kahn;Ele Ferrannini;Allison B. Goldfine

  • CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis.

    Ele Ferrannini;Michael Mark;Eric Mayoux

  • Erratum: Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (Diabetologia (2013) 56 (680))

    S. E. Inzucchi;R. M. Bergenstal;John B Buse;M. Diamant

Frequent Co-Authors

Amalia Gastaldelli
Amalia Gastaldelli National Research Council (CNR)
Alessandro Antonelli
Alessandro Antonelli University of Pisa
Pirjo Nuutila
Pirjo Nuutila Turku University Hospital
Mark Walker
Mark Walker University of Ottawa
Paul W. Franks
Paul W. Franks Lund University
Claudia Langenberg
Claudia Langenberg Queen Mary University of London
Erik Ingelsson
Erik Ingelsson Stanford University
Nicholas J. Wareham
Nicholas J. Wareham University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring the field of Medicine in the USA, there are several online degree options and career pathways to consider. Many students begin their journey in healthcare with nursing programs, which offer high demand and flexibility. Choosing cheap online fnp programs can help future nurse practitioners advance their careers without the burden of excessive debt.

For those seeking entry or advancement in nursing, there are a range of affordable online nursing programs available. These programs are ideal for students who need to balance studies with work or family obligations. Additionally, registered nurses can boost their credentials with the cheapest online bsn programs, further expanding their job prospects.

If you’re interested in leadership or research within healthcare, pursuing advanced degrees such as the cheapest phd nursing programs may be the right move. Online formats make it easier than ever to achieve these qualifications, providing flexibility and affordability for future healthcare professionals.

Best Scientists Citing Ele Ferrannini

Trending Scientists